UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Immunity (Cambridge, Mass.), 2012-09, Vol.37 (3), p.574-587

2012

Volltextzugriff (PDF)

Interplay between the immune system and adipose tissue in obesity

Journal of endocrinology, 2014-11, Vol.223 (2), p.R41-R48

2014

Volltextzugriff (PDF)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy

Frontiers in immunology, 2018-03, Vol.9, p.384-384

2018

Volltextzugriff (PDF)

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Clinical cancer research, 2017-07, Vol.23 (14), p.3510-3519

2017

Volltextzugriff (PDF)

What Makes MAITs Wait?

Immunity (Cambridge, Mass.), 2016-01, Vol.44 (1), p.7-9

Exley, Mark A.

2016

Volltextzugriff (PDF)

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

Nature communications, 2024-02, Vol.15 (1), p.974-974, Article 974

2024

Volltextzugriff (PDF)

A2aR adenosine receptor controls cytokine production in iNKT cells

European journal of immunology, 2010-03, Vol.40 (3), p.682-687

2010

Volltextzugriff (PDF)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

Frontiers in immunology, 2018-09, Vol.9, p.1990-1990

2018

Volltextzugriff (PDF)

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

Journal for immunotherapy of cancer, 2023-08, Vol.11 (8), p.e006880

2023

Volltextzugriff (PDF)

Exploiting CD1-restricted T cells for clinical benefit

Molecular immunology, 2021-04, Vol.132, p.126-131

2021

Volltextzugriff (PDF)

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide

PloS one, 2010-06, Vol.5 (6), p.e11311-e11311

2010

Volltextzugriff (PDF)

IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

Cancer immunology research, 2018-01, Vol.6 (1), p.25-35

2018

Volltextzugriff (PDF)

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals

Proceedings of the National Academy of Sciences - PNAS, 2007-04, Vol.104 (14), p.5971-5976

2007

Volltextzugriff (PDF)

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

Journal of Virology, 2007-06, Vol.81 (11), p.5882-5892

2007

Volltextzugriff (PDF)

Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection

PLoS pathogens, 2012-09, Vol.8 (9), p.e1002928-e1002928

2012

Volltextzugriff (PDF)

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α‐chain CDR3 loop

European journal of immunology, 2008-06, Vol.38 (6), p.1756-1766

2008

Volltextzugriff (PDF)

iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome

Clinical immunology (Orlando, Fla.), 2019-10, Vol.207, p.43-48

2019

Volltextzugriff (PDF)

Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity

Immunity (Cambridge, Mass.), 2017-02, Vol.46 (2), p.273-286

2017

Volltextzugriff (PDF)

Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection

PloS one, 2010-03, Vol.5 (3), p.e9787-e9787

2010

Volltextzugriff (PDF)

CD1d Ligation on Human Monocytes Directly Signals Rapid NF-κB Activation and Production of Bioactive IL-12

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (33), p.11811-11816

2005

Volltextzugriff (PDF)

Broad applicability of the Goldspire™ platform for the treatment of solid tumors

Clinical immunology (Orlando, Fla.), 2024-11, Vol.268, p.110373, Article 110373

2024

Volltextzugriff (PDF)

Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy

Clinical cancer research, 2008-11, Vol.14 (21), p.6955-6962

2008

Volltextzugriff (PDF)

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Journal of neuro-oncology, 2023-12, Vol.165 (3), p.389-398

2023

Volltextzugriff (PDF)

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Journal of neuro-oncology, 2024-04, Vol.167 (2), p.369-369

2024

Volltextzugriff (PDF)

Effects of the Administration of High-Dose Interleukin-2 on Immunoregulatory Cell Subsets in Patients with Advanced Melanoma and Renal Cell Cancer

Clinical cancer research, 2007-04, Vol.13 (7), p.2100-2108

2007

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Englisch
(225)

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(128)
Humans
(92)
Animals
(68)
Immunology
(62)
Mice
(54)
Female
(41)
Killer Cells, Natural - Immunology
(36)
Male
(36)
Mice, Inbred C57bl
(35)
Antigens, Cd1d
(26)
Natural Killer T-Cells - Immunology
(26)
Biological And Medical Sciences
(24)
Mice, Knockout
(24)
Middle Aged
(23)
Adult
(22)
T-Lymphocyte Subsets - Immunology
(19)
Cells, Cultured
(18)
Cytokines
(18)
Aged
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Interplay between the immune system and adipose tissue in obesity

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

What Makes MAITs Wait?

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

A2aR adenosine receptor controls cytokine production in iNKT cells

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

Exploiting CD1-restricted T cells for clinical benefit

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide

IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α‐chain CDR3 loop

iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome

Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity

Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection

CD1d Ligation on Human Monocytes Directly Signals Rapid NF-κB Activation and Production of Bioactive IL-12

Broad applicability of the Goldspire™ platform for the treatment of solid tumors

Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Effects of the Administration of High-Dose Interleukin-2 on Immunoregulatory Cell Subsets in Patients with Advanced Melanoma and Renal Cell Cancer

Suchergebnisse filtern